Editorial
Published on 14 Mar 2024
Editorial: Women in cytokines and soluble mediators in immunity
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1395165
- 379 views
Type at least 3 characters
1,058 articles
Articles
Original Research
Published on 12 Mar 2024
Early host immune responses in a human organoid-derived gallbladder monolayer to Salmonella Typhi strains from patients with acute and chronic infections: a comparative analysis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1334762
- 919 views
Original Research
Published on 11 Mar 2024
Association between loss of hypercoagulable phenotype, clinical features and complement pathway consumption in COVID-19
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1337070
- 1,047 views
Mini Review
Published on 08 Mar 2024
A mini-review: phosphodiesterases in charge to balance intracellular cAMP during T-cell activation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1365484
- 1,195 views
Original Research
Published on 08 Mar 2024
Revisiting roles of mast cells and neural cells in keloid: exploring their connection to disease activity
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1339336
- 1,676 views
Original Research
Published on 07 Mar 2024
Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1341804
- 1,268 views
Original Research
Published on 06 Mar 2024
Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1359555
- 871 views
Editorial
Published on 05 Mar 2024
Editorial: Role of carcinoembryonic antigen-related cell adhesion molecules in pathogen responses, tumorigenicity, and immune modulation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1388453
- 484 views
Original Research
Published on 28 Feb 2024
IL-6 signaling drives self-renewal and alternative activation of adipose tissue macrophages
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1201439
- 1,481 views
- 1 citation
Original Research
Published on 28 Feb 2024
IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1344963
- 1,542 views
Original Research
Published on 23 Feb 2024
Extracellular vesicles released by microglia and macrophages carry endocannabinoids which foster oligodendrocyte differentiation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1331210
- 1,922 views
Original Research
Published on 22 Feb 2024
Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1352583
- 1,339 views
Original Research
Published on 20 Feb 2024
The secretome of macrophages has a differential impact on spinal cord injury recovery according to the polarization protocol
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1354479
- 1,948 views
Original Research
Published on 15 Feb 2024
Time-resolved role of P2X4 and P2X7 during CD8+ T cell activation
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1258119
- 1,201 views
- 1 citation
Mini Review
Published on 15 Feb 2024
Purinergic enzymes on extracellular vesicles: immune modulation on the go
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1362996
- 1,384 views
Review
Published on 14 Feb 2024
Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1356321
- 1,689 views
- 1 citation